Table 1.
Position | Sequence | Name |
---|---|---|
−5 | 5′-ctcttagtcaggaaYatgtctctatgctgggagcaaaggc | Tg−5 |
3′-gagaatcagtccttatacaXagatacgaccctcgtttccg | ||
−1 | 5′-ctcttagtcaggaatatgYctctatgctgggagcaaaggc | Tg −1 |
3′-gagaatcagtccttatacaXagatacgaccctcgtttccg | ||
+1 | 5′-ctcttagtcaggaatatgtcYctatgctgggagcaaaggc | Tg + 1 |
3′-gagaatcagtccttatacaXagatacgaccctcgtttccg | ||
+5 | 5′-ctcttagtcaggaatatgtctctaYgctgggagcaaaggc | Tg + 5 |
3′-gagaatcagtccttatacaXagatacgaccctcgtttccg | ||
control 1 | 5′-ctcttagtcaggaatatgtctctatgctgggagcaaaggc | Control AP, Control 8-oxoG |
3′-gagaatcagtccttatacaXagatacgaccctcgtttccg | ||
control 2 | 5′-ctcttagtcaggaatatgYctctatgctgggagcaaaggc | Control Tg |
3′-gagaatcagtccttatacagagatacgaccctcgtttccg | ||
control 3 | 5′-ctcttagtcaggaatatgtctctatgctgggagcaaaggc | No damage |
3′-gagaatcagtccttatacagagatacgaccctcgtttccg |
X represents either 8-oxoG, an AP site or a HAP1-SSB (following conversion of uracil to AP site and to a HAP1-SSB as described in Materials and Methods section); Y represents thymine glycol. −5 and −1 indicate the positions on the complementary strand of the X base 3′ from Y base. +1 and +5 are the positions on the complementary strand of the X base 5′ from the Y base. Control 1 is control oligonucleotide containing ether an AP site, a HAP1-SSB or 8-oxoG as a single lesion. Control 2 is the control oligonucleotide containing Tg as a single lesion. Control 3 is the control oligonucleotide containing no damage.